Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 9:27 AM ET


Company Overview of Thallion Pharmaceuticals, Inc.

Company Overview

Thallion Pharmaceuticals Inc., a biotechnology company, engages in the development of pharmaceutical products in the areas of infectious diseases and oncology. Its lead product candidate includes Shigamabs, a dual antibody product that is in a Phase II clinical trial for the treatment of Shigatoxin-producing E. coli bacterial infections. The company also owns a proprietary technology platform, DECIPHER, a genomics-based discovery platform for identifying novel secondary metabolites from non-pathogenic microorganisms. Its other clinical program includes TLN-4601, a novel small molecule with potential to treat multiple cancer indications, including solid and liquid tumors. Thallion Pharmaceuti...

1375 TransCanada Highway

Suite 200

Dorval, QC H9P 2W8


Founded in 1998

13 Employees





Key Executives for Thallion Pharmaceuticals, Inc.

Thallion Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Fast Genetics Inc. Americas
Angiochem Inc. Americas
AquaBounty Canada, Inc. Americas
Asmacure Ltée Americas
Prevtec Microbia Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Thallion Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at